My Quote Request
No products added yet
6505-01-316-5044
20 Products
NDC00009-3375-02
CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION
NSN, MFG P/N
6505013165044
NSN
6505-01-316-5044
NDC00009-3375-02
CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION
NSN, MFG P/N
6505013165044
NSN
6505-01-316-5044
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION 50ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: IN 5 PERCENT DEXTROSE; SINGLE DOSE; BAG WITH AT LEASE ONE OUTLET PORT TO ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS; SECOND OUTLET PORT IF PROVIDED SHALL HAVE RUBBER LATEX SLEEVE OR NATURAL RUBBER STOPPER SUITABLE FOR INJECTION SITE;
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: (DEXTROSE IS 5 PERCENT IN WATER AS A STERILE SOLUTION)
Related Searches:
CLEOCIN INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION
NSN, MFG P/N
6505013165044
NSN
6505-01-316-5044
CLEOCIN INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION
NSN, MFG P/N
6505013165044
NSN
6505-01-316-5044
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION 50ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: IN 5 PERCENT DEXTROSE; SINGLE DOSE; BAG WITH AT LEASE ONE OUTLET PORT TO ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED IV SETS; SECOND OUTLET PORT IF PROVIDED SHALL HAVE RUBBER LATEX SLEEVE OR NATURAL RUBBER STOPPER SUITABLE FOR INJECTION SITE;
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: (DEXTROSE IS 5 PERCENT IN WATER AS A STERILE SOLUTION)
Related Searches:
NDC00904-5464-20
IBUPROFEN ORAL SUSPENSION,USP
NSN, MFG P/N
6505013165049
NSN
6505-01-316-5049
NDC00904-5464-20
IBUPROFEN ORAL SUSPENSION,USP
NSN, MFG P/N
6505013165049
NSN
6505-01-316-5049
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS IBUPROFEN PER 5 MILLILITERS
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
FLAVOR: FRUIT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IBUPROFEN ORAL SUSPENSION USP 100MG/5ML FRUIT FLAVORED 120ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS OR 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
1K0196
PIPERACILLIN SODIUM
NSN, MFG P/N
6505013165051
NSN
6505-01-316-5051
MFG
BAXTER HEALTHCARE CORP
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 2 GRAMS PIPERACILLIN; PREMIXED,STERILE,NON-PYROGENIC SOLUTION IN 5 % DEXTROSE,FROZEN; SINGLE DOSE 50 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE WITH STOCKLISTED INTRAVENOUS INJECTION SETS; FOR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
~1: INTRAVENOUS INFUSION 24'S
Related Searches:
NDC00338-2003-41
PIPERACILLIN SODIUM
NSN, MFG P/N
6505013165051
NSN
6505-01-316-5051
MFG
BAXTER HEALTHCARE CORP
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 2 GRAMS PIPERACILLIN; PREMIXED,STERILE,NON-PYROGENIC SOLUTION IN 5 % DEXTROSE,FROZEN; SINGLE DOSE 50 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE WITH STOCKLISTED INTRAVENOUS INJECTION SETS; FOR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
~1: INTRAVENOUS INFUSION 24'S
Related Searches:
PIPRACIL INJECTION
PIPERACILLIN SODIUM
NSN, MFG P/N
6505013165051
NSN
6505-01-316-5051
PIPRACIL INJECTION
PIPERACILLIN SODIUM
NSN, MFG P/N
6505013165051
NSN
6505-01-316-5051
MFG
BAXTER HEALTHCARE CORP
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EQUIVALENT TO 2 GRAMS PIPERACILLIN; PREMIXED,STERILE,NON-PYROGENIC SOLUTION IN 5 % DEXTROSE,FROZEN; SINGLE DOSE 50 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE WITH STOCKLISTED INTRAVENOUS INJECTION SETS; FOR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
~1: INTRAVENOUS INFUSION 24'S
Related Searches:
NDC00338-0471-03
AMINO ACID INJECTION
NSN, MFG P/N
6505013165061
NSN
6505-01-316-5061
NDC00338-0471-03
AMINO ACID INJECTION
NSN, MFG P/N
6505013165061
NSN
6505-01-316-5061
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 500ML BT 12 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.0 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
RENAMIN
AMINO ACID INJECTION
NSN, MFG P/N
6505013165061
NSN
6505-01-316-5061
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 500ML BT 12 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.0 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
RENAMIN 6.5%
AMINO ACID INJECTION
NSN, MFG P/N
6505013165061
NSN
6505-01-316-5061
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 500ML BT 12 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.0 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
AMINOSYN-HBC
AMINO ACID INJECTION
NSN, MFG P/N
6505013165062
NSN
6505-01-316-5062
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML BT 6 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.12 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
AMINOSYN-HBC 7%
AMINO ACID INJECTION
NSN, MFG P/N
6505013165062
NSN
6505-01-316-5062
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML BT 6 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.12 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00074-1108-05
AMINO ACID INJECTION
NSN, MFG P/N
6505013165062
NSN
6505-01-316-5062
NDC00074-1108-05
AMINO ACID INJECTION
NSN, MFG P/N
6505013165062
NSN
6505-01-316-5062
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 1000ML BT 6 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.12 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
AMINOSYN-HBC
AMINO ACID INJECTION
NSN, MFG P/N
6505013165064
NSN
6505-01-316-5064
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 500ML BT 12 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.12 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
AMINOSYN-HBC 7%
AMINO ACID INJECTION
NSN, MFG P/N
6505013165064
NSN
6505-01-316-5064
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 500ML BT 12 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.12 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-1108-03
AMINO ACID INJECTION
NSN, MFG P/N
6505013165064
NSN
6505-01-316-5064
NDC00074-1108-03
AMINO ACID INJECTION
NSN, MFG P/N
6505013165064
NSN
6505-01-316-5064
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 7.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 500ML BT 12 BT PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: 1.12 GRAMS NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
12083
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013165679
NSN
6505-01-316-5679
12083
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013165679
NSN
6505-01-316-5679
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CYPROHEPTADINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1132-10
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013165679
NSN
6505-01-316-5679
NDC00182-1132-10
CYPROHEPTADINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013165679
NSN
6505-01-316-5679
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS CYPROHEPTADINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
487827
SELEGILINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013166024
NSN
6505-01-316-6024
487827
SELEGILINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013166024
NSN
6505-01-316-6024
MFG
BERGEN BRUNSWIG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS SELEGILINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SELEGILINE HYDROCHLORIDE TABLETS USP 5MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC55953-0179-35
SELEGILINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013166024
NSN
6505-01-316-6024
NDC55953-0179-35
SELEGILINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013166024
NSN
6505-01-316-6024
MFG
NOVOPHARM USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS SELEGILINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SELEGILINE HYDROCHLORIDE TABLETS USP 5MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59911-3254-01
SELEGILINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013166024
NSN
6505-01-316-6024
NDC59911-3254-01
SELEGILINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013166024
NSN
6505-01-316-6024
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS SELEGILINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SELEGILINE HYDROCHLORIDE TABLETS USP 5MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
